Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

STEFs: Activated Vinylogous Protein-Reactive Electrophiles.

Hansen BK, Loveridge CJ, Thyssen S, Wørmer GJ, Nielsen AD, Palmfeldt J, Johannsen M, Poulsen TB.

Angew Chem Int Ed Engl. 2019 Mar 11;58(11):3533-3537. doi: 10.1002/anie.201814073. Epub 2019 Feb 7.

PMID:
30618057
2.

Patient Characteristics and Treatment Patterns Among Psychiatrists Who Do Not Accept Private Insurance.

Busch SH, Ndumele CD, Loveridge CF, Kyanko KA.

Psychiatr Serv. 2019 Jan 1;70(1):35-39. doi: 10.1176/appi.ps.201800014. Epub 2018 Nov 20.

PMID:
30453856
3.

Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.

Patel R, Fleming J, Mui E, Loveridge C, Repiscak P, Blomme A, Harle V, Salji M, Ahmad I, Teo K, Hamdy FC, Hedley A, van den Broek N, Mackay G, Edwards J, Sansom OJ, Leung HY.

EMBO Mol Med. 2018 Apr;10(4). pii: e8347. doi: 10.15252/emmm.201708347.

4.

Analysis of Nkx3.1:Cre-driven Erk5 deletion reveals a profound spinal deformity which is linked to increased osteoclast activity.

Loveridge CJ, van 't Hof RJ, Charlesworth G, King A, Tan EH, Rose L, Daroszewska A, Prior A, Ahmad I, Welsh M, Mui EJ, Ford C, Salji M, Sansom O, Blyth K, Leung HY.

Sci Rep. 2017 Oct 16;7(1):13241. doi: 10.1038/s41598-017-13346-8.

5.

Increased T-cell Infiltration Elicited by Erk5 Deletion in a Pten-Deficient Mouse Model of Prostate Carcinogenesis.

Loveridge CJ, Mui EJ, Patel R, Tan EH, Ahmad I, Welsh M, Galbraith J, Hedley A, Nixon C, Blyth K, Sansom O, Leung HY.

Cancer Res. 2017 Jun 15;77(12):3158-3168. doi: 10.1158/0008-5472.CAN-16-2565. Epub 2017 May 17.

6.

Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.

Ahmad I, Mui E, Galbraith L, Patel R, Tan EH, Salji M, Rust AG, Repiscak P, Hedley A, Markert E, Loveridge C, van der Weyden L, Edwards J, Sansom OJ, Adams DJ, Leung HY.

Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):8290-5. doi: 10.1073/pnas.1601571113. Epub 2016 Jun 29.

7.

Performance on the Farnsworth-Munsell 100-Hue Test Is Significantly Related to Nonverbal IQ.

Cranwell MB, Pearce B, Loveridge C, Hurlbert AC.

Invest Ophthalmol Vis Sci. 2015 May;56(5):3171-8. doi: 10.1167/iovs.14-16094.

PMID:
26024100
8.

p300-mediated acetylation of COMMD1 regulates its stability, and the ubiquitylation and nucleolar translocation of the RelA NF-κB subunit.

O'Hara A, Simpson J, Morin P, Loveridge CJ, Williams AC, Novo SM, Stark LA.

J Cell Sci. 2014 Sep 1;127(Pt 17):3659-65. doi: 10.1242/jcs.149328. Epub 2014 Jul 29.

9.

Conflicting standards for diagnostic spirometry within-session repeatability are confusing.

Gruffydd-Jones K, Pinnock H, Loveridge C, Wolfe S, McArthur R, Bellamy D.

Prim Care Respir J. 2012 Jun;21(2):136. doi: 10.4104/pcrj.2012.00044. No abstract available.

10.

c-Src dependency of NSAID-induced effects on NF-κB-mediated apoptosis in colorectal cancer cells.

Brady RR, Loveridge CJ, Dunlop MG, Stark LA.

Carcinogenesis. 2011 Jul;32(7):1069-77. doi: 10.1093/carcin/bgr077. Epub 2011 May 5.

PMID:
21551129
11.

The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines?

Gruffydd-Jones K, Loveridge C.

Prim Care Respir J. 2011 Jun;20(2):199-204. doi: 10.4104/pcrj.2011.00011.

12.

What provokes experienced COPD clinical practitioners in the UK to initiate or change medication? A consensus study.

Upton J, McCutcheon E, Loveridge C, Wiggins J, Walker S, Fletcher M.

Prim Care Respir J. 2011 Jun;20(2):155-60, 2 p following 160. doi: 10.4104/pcrj.2011.00008.

13.

The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.

Loveridge C, Tonelli F, Leclercq T, Lim KG, Long JS, Berdyshev E, Tate RJ, Natarajan V, Pitson SM, Pyne NJ, Pyne S.

J Biol Chem. 2010 Dec 10;285(50):38841-52. doi: 10.1074/jbc.M110.127993. Epub 2010 Oct 6.

14.

FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.

Tonelli F, Lim KG, Loveridge C, Long J, Pitson SM, Tigyi G, Bittman R, Pyne S, Pyne NJ.

Cell Signal. 2010 Oct;22(10):1536-42. doi: 10.1016/j.cellsig.2010.05.022. Epub 2010 Jun 4.

15.

Assessment of psychosocial problems in primary care COPD patients.

Upton J, Madoc-Sutton H, Loveridge C, Sheikh A, Walker S, Fletcher M.

Br J Nurs. 2010 May 13-26;19(9):554-7.

PMID:
20505577
16.

Recommendations on repeatability of spirometry.

Fletcher M, Loveridge C.

Prim Care Respir J. 2010 Jun;19(2):192; author reply 193. doi: 10.4104/pcrj.2010.00026. No abstract available.

17.

Nucleolar targeting of RelA(p65) is regulated by COMMD1-dependent ubiquitination.

Thoms HC, Loveridge CJ, Simpson J, Clipson A, Reinhardt K, Dunlop MG, Stark LA.

Cancer Res. 2010 Jan 1;70(1):139-49. doi: 10.1158/0008-5472.CAN-09-1397.

18.

New aspects of sphingosine 1-phosphate signaling in mammalian cells.

Pyne NJ, Long JS, Lee SC, Loveridge C, Gillies L, Pyne S.

Adv Enzyme Regul. 2009;49(1):214-21. doi: 10.1016/j.advenzreg.2009.01.011. Review. No abstract available.

PMID:
19534035
19.

The proapoptotic effects of sulindac, sulindac sulfone and indomethacin are mediated by nucleolar translocation of the RelA(p65) subunit of NF-kappaB.

Loveridge CJ, MacDonald AD, Thoms HC, Dunlop MG, Stark LA.

Oncogene. 2008 Apr 17;27(18):2648-55. Epub 2007 Dec 3.

PMID:
18059344
20.

Raising the profile of women's health.

Loveridge C.

RCM Midwives. 2005 Oct;8(10):412-3. No abstract available.

PMID:
16250157
21.

The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells.

Collier B, Gorgoni B, Loveridge C, Cooke HJ, Gray NK.

EMBO J. 2005 Jul 20;24(14):2656-66. Epub 2005 Jul 7.

22.

Help wanted!

Loveridge C.

RCM Midwives. 2005 Apr;8(4):174. No abstract available.

PMID:
15839145
24.

Communicating, coordinating, and collaborating through diversity.

Loveridge CE.

Adv Pract Nurs Q. 1996 Fall;2(2):75-8.

PMID:
9447078
25.

How to critique a research study.

Fosbinder D, Loveridge C.

Adv Pract Nurs Q. 1996 Winter;2(3):68-71. Review.

PMID:
9447093
26.

Preparing the workforce for managed care.

Loveridge CE.

Semin Nurse Manag. 1995 Jun;3(2):89-94.

PMID:
7627603
27.

From nursing service to professional practice.

Parkman CA, Loveridge C.

Nurs Manage. 1994 Mar;25(3):63-8.

PMID:
7510861
28.

Trends in nursing administration graduate education.

Ludemann RS, Loveridge CE.

J Nurs Adm. 1992 Nov;22(11):9-10, 20. No abstract available.

PMID:
1432235
29.

Lessons in excellence for nurse administrators.

Loveridge CE.

Nurs Manage. 1991 May;22(5):46-7. No abstract available.

PMID:
2027632
30.

The new nursing organization.

O'Malley J, Loveridge CE, Cummings SH.

Nurs Manage. 1989 Feb;20(2):29-32. No abstract available.

PMID:
2922163
31.

Developing case management in a primary nursing system.

Loveridge CE, Cummings SH, O'Malley J.

J Nurs Adm. 1988 Oct;18(10):36-9.

PMID:
3171714
32.

Critical thinking and fatigue: how do nurses on 8- & 12-hour shifts compare?

Fields WL, Loveridge C.

Nurs Econ. 1988 Jul-Aug;6(4):189-95. No abstract available.

PMID:
2900476
33.

Contingency theory: explaining staff nurse retention.

Loveridge CE.

J Nurs Adm. 1988 Jun;18(6):22-5.

PMID:
3373327
34.

Confirming interactions.

Loveridge CE, Heineken J.

J Gerontol Nurs. 1988 May;14(5):27-30. No abstract available.

PMID:
3372967
35.

Study tour in England. The guests' programme.

Loveridge C.

World Hosp. 1982 Nov;18(4):32-5. No abstract available.

PMID:
10258119
36.

Instrument development: measuring quality outcomes in ambulatory maternal-child nursing.

Blair EM, Hauf B, Loveridge C, Murphy J, Roth M.

Nurs Adm Q. 1978 Summer;2(4):81-93. No abstract available.

PMID:
249368

Supplemental Content

Loading ...
Support Center